Alnylam Pharmaceuticals, Inc.

COMMERCE BANK ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

10,533

Value ($000)

4,188

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	4,188	0.0%	10,533	12/31/2025
2025 Q3	11/12/2025	2,066	0.0%	4,531	9/30/2025
2025 Q2	8/7/2025	1,479	0.0%	4,536	6/30/2025
2025 Q1	5/8/2025	1,230	0.0%	4,557	3/31/2025
2024 Q4	2/13/2025	1,059	0.0%	4,502	12/31/2024
2024 Q3	11/8/2024	1,244	0.0%	4,522	9/30/2024
2024 Q2	8/12/2024	1,122	0.0%	4,617	6/30/2024
2024 Q1	5/3/2024	696	0.0%	4,656	3/31/2024
2023 Q4	2/9/2024	896	0.0%	4,683	12/31/2023
2023 Q3	11/14/2023	816	0.0%	4,606	9/30/2023
2023 Q2	8/8/2023	870	0.0%	4,578	6/30/2023
2023 Q1	5/4/2023	923	0.0%	4,608	3/31/2023
2022 Q4	2/10/2023	1,058	0.0%	4,450	12/31/2022
2022 Q3	11/4/2022	896	0.0%	4,477	9/30/2022
2022 Q2	8/12/2022	3,595	0.0%	24,647	6/30/2022
2022 Q1	5/9/2022	712	0.0%	4,358	3/31/2022
2021 Q4	2/14/2022	722	0.0%	4,258	12/31/2021
2021 Q3	11/9/2021	800	0.0%	4,237	9/30/2021
2021 Q2	8/9/2021	990	0.0%	5,841	6/30/2021
2021 Q1	5/5/2021	817	0.0%	5,788	3/31/2021
2020 Q4	2/9/2021	5,145	0.0%	39,586	12/31/2020
2020 Q3	11/6/2020	5,028	0.0%	34,535	9/30/2020
2020 Q2	8/7/2020	4,631	0.0%	31,268	6/30/2020
2020 Q1	5/8/2020	488	0.0%	4,480	3/31/2020
2019 Q4	2/14/2020	356	0.0%	3,090	12/31/2019